Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Major Depressive Disorder Patients”

Showing 20 of 0 results

Large-scale testing (Phase 3)Ended earlyNCT01111565
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder (MDD)
Otsuka Pharmaceutical Development & Commercialization, Inc. 137
Not applicableStudy completedNCT00229398
What this trial is testing

Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression Disorder

Who this might be right for
Major Depressive Disorder
Sheba Medical Center
Not applicableEnrolling By InvitationNCT05703412
What this trial is testing

Effectiveness of mHealth Post-discharge Intervention for Patients With Severe Mental Illness

Who this might be right for
Bipolar DisorderMajor DepressionSchizophrenia
Butler Hospital 180
Large-scale testing (Phase 3)Study completedNCT05061719
What this trial is testing

An Open-label Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Intra-Cellular Therapies, Inc. 812
Post-approval studies (Phase 4)Study completedNCT00595699
What this trial is testing

Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy

Who this might be right for
Major DepressionTemporal Lobe Epilepsy
Conrad, Erich J., M.D. 8
Large-scale testing (Phase 3)Study completedNCT01370499
What this trial is testing

LY2216684 in Participants With Major Depression Disorder

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 288
Post-approval studies (Phase 4)Study completedNCT00536471
What this trial is testing

A Study Comparing Duloxetine and Placebo in Assessing Energy and Vitality in Major Depressive Disorder (MDD) Patients

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 776
Not applicableUnknownNCT06270433
What this trial is testing

Efficacy and Safety of Toludesvenlafaxine Hydrochloride Sustained-release Tablets Versus Desvenlafaxine Succinate Sustained-release Tablets Targeting Anhedonia in Patients With Major Depression Disorder

Who this might be right for
Anhedonia
Jiangsu Province Nanjing Brain Hospital 80
Large-scale testing (Phase 3)Study completedNCT00035009
What this trial is testing

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-059)

Who this might be right for
Major Depressive Disorder
Merck Sharp & Dohme LLC 468
Not applicableUnknownNCT04199845
What this trial is testing

8-week of PS128 RCT in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Taipei Medical University WanFang Hospital 60
Not applicableStudy completedNCT00369746
What this trial is testing

STAR*D Alcohol: Treatment of Depression Concurrent With Alcohol Abuse

Who this might be right for
Major Depressive DisorderAlcohol Use Disorder
New York State Psychiatric Institute 674
Testing effectiveness (Phase 2)Study completedNCT04395183
What this trial is testing

5-HTP and Creatine for Depression

Who this might be right for
Major Depressive Disorder
University of Utah 43
Large-scale testing (Phase 3)Study completedNCT00128505
What this trial is testing

An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Corcept Therapeutics 104
Not applicableWithdrawnNCT04829669
What this trial is testing

Participants With Moderate or Severe Major Depressive Disorder (MDD) Requiring Urgent Symptom Control in a Psychiatric Emergency

Who this might be right for
Depressive Disorder, Major
Janssen-Cilag Ltd.
Post-approval studies (Phase 4)Study completedNCT01075529
What this trial is testing

Early Prediction of Fluoxetine Response

Who this might be right for
Major Depressive Disorder
Kaohsiung Kai-Suan Psychiatric Hospital 140
Not applicableStudy completedNCT01431001
What this trial is testing

Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression

Who this might be right for
Major Depressive Disorder
Cervel Neurotech, Inc. 40
Post-approval studies (Phase 4)UnknownNCT00650897
What this trial is testing

Efficacy Study of Escitalopram for Depression in Patients With Diabetes

Who this might be right for
Major DepressionDiabetes Mellitus
Sheba Medical Center 30
Post-approval studies (Phase 4)Study completedNCT01035073
What this trial is testing

Functional Change and Efficacy of Duloxetine in Patients With Co-Morbid Depression & Soft Tissue Discomfort Syndrome

Who this might be right for
Major Depressive DisorderSoft Tissue Discomfort SyndromePain
University of Pennsylvania 22
Testing effectiveness (Phase 2)Study completedNCT00844922
What this trial is testing

Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)

Who this might be right for
Depressive DisordersPsychotic DisordersDepression
Merck Sharp & Dohme LLC 16
Post-approval studies (Phase 4)Study completedNCT02332954
What this trial is testing

Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine

Who this might be right for
Major Depressive Disorder
Lundbeck Canada Inc. 226
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation